2016
DOI: 10.1097/ta.0000000000000962
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations for venous thromboembolism prophylaxis in pediatric trauma patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
32
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 25 publications
(35 citation statements)
references
References 24 publications
2
32
0
1
Order By: Relevance
“…In total, 21 of 117 very high risk patients received prophylaxis starting median (IQR) hospital day 6 (3-8); 19/21 were screened in compliance with the protocol and none developed VTE. These patients were median (IQR) age 12 (14)(15)(16) Area under the receiver operating characteristic curve = 0.9; Hosmer-Lemeshow GOF test = NS; variance inflation factor less than 10.…”
Section: Long-term Follow-upmentioning
confidence: 99%
See 2 more Smart Citations
“…In total, 21 of 117 very high risk patients received prophylaxis starting median (IQR) hospital day 6 (3-8); 19/21 were screened in compliance with the protocol and none developed VTE. These patients were median (IQR) age 12 (14)(15)(16) Area under the receiver operating characteristic curve = 0.9; Hosmer-Lemeshow GOF test = NS; variance inflation factor less than 10.…”
Section: Long-term Follow-upmentioning
confidence: 99%
“…Information regarding chemical prophylaxis or screening protocols in injured children is even more limited. As a result, there is wide variation in the field of pediatric trauma regarding VTE practices, and expert consensus is limited regarding risk factors, indications and utilization of prophylaxis, and bleeding risks …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Published pediatric guidelines are based on weak evidence and recommend against the use of pharmacologic prophylaxis except in children with cyanotic congenital heart disease, dilated cardiomyopathy, cavopulmonary anastomosis, end-stage renal disease, and primary pulmonary hypertension (24). A recently published consensus of experts in regards to pediatric trauma recommended against prophylaxis in children <12 years of age and gave a strong recommendation for pharmacologic prophylaxis in patients with a history of VTE, while a weak recommendation for patients with CVCs (25). Given the lack of data, it is not surprising that there is a wide variation in thromboprophylactic practices in critically ill children as shown in the PROTRACT study (26).…”
Section: Prevention Of Vte In Critically Ill or Injured Childrenmentioning
confidence: 99%
“…8,23 Patients less than 12 years of age are considered to have a very low risk of developing DVT. 27 However, this consideration is based on either retrospective trauma data or tradition.…”
mentioning
confidence: 99%